Tarun Kewalramani to Antineoplastic Agents, Alkylating
This is a "connection" page, showing publications Tarun Kewalramani has written about Antineoplastic Agents, Alkylating.
Connection Strength
0.061
-
Comenzo RL, Hassoun H, Kewalramani T, Klimek V, Dhodapkar M, Reich L, Teruya-Feldstein J, Fleisher M, Filippa D, Nimer SD. Results of a phase I/II trial adding carmustine (300 mg/m2) to melphalan (200 mg/m2) in multiple myeloma patients undergoing autologous stem cell transplantation. Leukemia. 2006 Feb; 20(2):345-9.
Score: 0.061